Combination therapy of respiratory diseases using antibodies

Details for Australian Patent Application No. 2001259379 (hide)

Owner Medimmune, Inc.

Inventors Johnson, Leslie S.

Agent Spruson & Ferguson

Pub. Number AU-B-2001259379

PCT Pub. Number WO01/82965

Priority 60201402 03.05.00 US

Filing date 3 May 2001

Wipo publication date 12 November 2001

Acceptance publication date 3 August 2006

International Classifications

A61K 39/42 (2006.01) Medicinal preparations containing antigens or antibodies - viral

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

3 August 2006 Application Accepted

  Published as AU-B-2001259379

7 December 2006 Standard Patent Sealed

9 October 2008 Alteration of Name

  The name of the patentee has been altered to MedImmune, LLC

27 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001259380-System and method for adaptive drug delivery

2001259378